May 31st 2025
"There was activity across all the groups from an EFS perspective," said Thomas B. Powles, MBBS, MRCP, MD.
How rBCG EAP could open up access for Anktiva in bladder cancer
April 11th 2025“I feel a lot of providers, with Antiva being available, have unfortunately reserved use of this great FDA-approved agent for BCG-unresponsive patients because of the supply issue with BCG," says Suzanne B. Merrill, MD, FACS.